Central Proteina (Indonesia) Buy Hold or Sell Recommendation
CPRO Stock | IDR 50.00 0.00 0.00% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Central Proteina Prima is 'Cautious Hold'. The recommendation algorithm takes into account all of Central Proteina's available fundamental, technical, and predictive indicators you will find on this site.
Check out Central Proteina Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Central and provide practical buy, sell, or hold advice based on investors' constraints. Central Proteina Prima. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Central |
Execute Central Proteina Buy or Sell Advice
The Central recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Central Proteina Prima. Macroaxis does not own or have any residual interests in Central Proteina Prima or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Central Proteina's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Central Proteina Trading Alerts and Improvement Suggestions
Central Proteina Prima has accumulated 1.06 T in total debt. Central Proteina Prima has a current ratio of 0.32, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Central Proteina until it has trouble settling it off, either with new capital or with free cash flow. So, Central Proteina's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Central Proteina Prima sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Central to invest in growth at high rates of return. When we think about Central Proteina's use of debt, we should always consider it together with cash and equity. | |
About 49.0% of the company shares are held by company insiders |
Central Proteina Returns Distribution Density
The distribution of Central Proteina's historical returns is an attempt to chart the uncertainty of Central Proteina's future price movements. The chart of the probability distribution of Central Proteina daily returns describes the distribution of returns around its average expected value. We use Central Proteina Prima price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Central Proteina returns is essential to provide solid investment advice for Central Proteina.
Mean Return | 0.01 | Value At Risk | -1.96 | Potential Upside | 0.00 | Standard Deviation | 1.04 |
Return Density |
Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Central Proteina historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Central Proteina Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Central Proteina or Food Products sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Central Proteina's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Central stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.01 | |
β | Beta against Dow Jones | 0.05 | |
σ | Overall volatility | 1.00 | |
Ir | Information ratio | -0.13 |
Central Proteina Volatility Alert
Central Proteina Prima exhibits very low volatility with skewness of 2.2 and kurtosis of 19.87. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Central Proteina's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Central Proteina's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Central Proteina Fundamentals Vs Peers
Comparing Central Proteina's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Central Proteina's direct or indirect competition across all of the common fundamentals between Central Proteina and the related equities. This way, we can detect undervalued stocks with similar characteristics as Central Proteina or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Central Proteina's fundamental indicators could also be used in its relative valuation, which is a method of valuing Central Proteina by comparing valuation metrics with those of similar companies.
Better Than Average | Worse Than Average | Compare Central Proteina to competition |
Fundamentals | Central Proteina | Peer Average |
Return On Equity | 0.13 | -0.31 |
Return On Asset | 0.0811 | -0.14 |
Profit Margin | 0.05 % | (1.27) % |
Operating Margin | 0.11 % | (5.51) % |
Current Valuation | 5.48 T | 16.62 B |
Shares Outstanding | 40.47 B | 571.82 M |
Shares Owned By Insiders | 48.75 % | 10.09 % |
Price To Book | 1.02 X | 9.51 X |
Price To Sales | 0.39 X | 11.42 X |
Revenue | 8.03 T | 9.43 B |
Gross Profit | 1.51 T | 27.38 B |
EBITDA | 2.6 T | 3.9 B |
Net Income | 2.21 T | 570.98 M |
Cash And Equivalents | 158.78 B | 2.7 B |
Cash Per Share | 2.66 X | 5.01 X |
Total Debt | 1.06 T | 5.32 B |
Current Ratio | 0.33 X | 2.16 X |
Book Value Per Share | 52.78 X | 1.93 K |
Cash Flow From Operations | 99.21 B | 971.22 M |
Earnings Per Share | 6.30 X | 3.12 X |
Number Of Employees | 1.78 K | 18.84 K |
Beta | -0.12 | -0.15 |
Market Capitalization | 3.1 T | 19.03 B |
Total Asset | 6.45 T | 29.47 B |
Z Score | 2.2 | 8.72 |
Net Asset | 6.45 T |
Central Proteina Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Central . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Central Proteina Buy or Sell Advice
When is the right time to buy or sell Central Proteina Prima? Buying financial instruments such as Central Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Central Proteina in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marijuana Thematic Idea Now
Marijuana
Small and mid-cap equities that are involved in production and delivery of Marijuana products. This theme is designed for investors that are willing to accept higher levels of market risk inherited by Marijuana production in the United States. The Marijuana theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marijuana Theme or any other thematic opportunities.
View All Next | Launch |
Other Information on Investing in Central Stock
Central Proteina financial ratios help investors to determine whether Central Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Central with respect to the benefits of owning Central Proteina security.